Showing results (81-90 of 167) with videos related to

Sort By:
Pageof 17
Cancer Gene Therapy|October 7, 2000
Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patientsS Fujii, S Huang, T C Fong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
A phase I trial of c-Raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancerC C Cunningham, J T Holmlund, J H Schiller, et al.
Blood|June 1, 1995
A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopeniaM S Gordon, J Nemunaitis, R Hoffman, et al.
Blood|September 1, 1991
Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantationJ A Bianco, F R Appelbaum, J Nemunaitis, et al.
Cancer Treatment and Research Communications|January 10, 2022
Subclonal landscape of cancer drives resistance to immune therapyDaniel J Craig, Morgan M Bailey, Olivia B Noe, et al.
Cancer Gene Therapy|January 18, 2006
Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX vaccine in advanced-stage non-small-cell lung cancerJ Nemunaitis, T Jahan, H Ross, et al.
Transfusion|November 1, 1995
Transfusion of donor buffy coat cells in the treatment of persistent or recurrent malignancy after allogeneic bone marrow transplantationR H Collins, L A Pineiro, J J Nemunaitis, et al.
Transfusion|August 1, 1995
Allogeneic transplantation combining mobilized blood and bone marrow in patients with refractory hematologic malignanciesJ Nemunaitis, C Rosenfeld, R Collins, et al.
Seminars in Oncology|October 18, 2001
Gene therapy approaches for the management of non-small cell lung cancerJ A Roth, S F Grammer, S G Swisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Randomized, placebo-controlled, multicenter trial of granulocyte-macrophage colony-stimulating factor as infection prophylaxis in oncologic surgery. Leukine Surgical Prophylaxis Research GroupN J Meropol, D E Wood, J Nemunaitis, et al.
Pageof 17